What Happened to Tommy John Surgery (Ulnar Collateral Ligament Reconstruction)?

Tommy John Surgery, officially Ulnar Collateral Ligament (UCL) Reconstruction, originated from a desperate need to save the career of Major League Baseball pitcher Tommy John. In 1974, John suffered a complete tear of his UCL, an injury then considered career-ending. Dr. Frank Jobe, a pioneering orthopedic surgeon for the Los Angeles Dodgers, devised an experimental procedure to replace the torn ligament with a tendon harvested from John's right wrist. At the time, Jobe estimated only a 1 in 100 chance of success. The surgery was a success, and John returned to pitch for 14 more seasons, winning 164 games after the operation, solidifying the procedure's viability and giving it its famous moniker.

The procedure's initial success paved the way for its widespread adoption, particularly among baseball pitchers, whose elbows endure immense stress during the throwing motion. The original technique involved detaching the flexor-pronator mass to access the UCL, creating bone tunnels, and weaving the graft through them. Over the decades, surgical techniques have evolved, including the Modified Jobe procedure and muscle-splitting approaches, aiming to minimize invasiveness and complications like ulnar nerve damage.

A significant turning point came with the increasing incidence of UCL injuries, not just in professional athletes but also in younger, amateur players. Factors like increased throwing velocity, higher spin rates, early sports specialization, and year-round play have contributed to this epidemic. By 2023, over 1,000 professional baseball pitchers had undergone the procedure, with 35.3% of active major-league pitchers having had it. This rise spurred further innovation in surgical approaches and rehabilitation protocols.

In recent years, a notable advancement is the UCL repair with internal brace augmentation, pioneered by Dr. Jeffrey Dugas. This technique involves reattaching the native UCL and reinforcing it with a synthetic internal brace, rather than a full replacement. For appropriate candidates, typically those with tears near the bone attachment and healthy remaining ligament tissue, this procedure can significantly reduce recovery time, often allowing a return to sport in 6-9 months, compared to the 12-18 months for traditional reconstruction. Hybrid procedures, combining traditional reconstruction with an internal brace, are also gaining traction, aiming for enhanced stability and potentially faster healing.

As of August 2026, Tommy John Surgery remains a cornerstone of sports medicine. Success rates for returning to prior levels of play are high, ranging from 80-95%, with some 2026 data indicating up to a 92% success rate for return to sport. The average recovery time for MLB pitchers has seen a slight decrease, from 16.2 months (2018-2020) to 14.2 months (2024-2026), reflecting improved surgical techniques and rehabilitation protocols. However, the issue of revision surgeries persists, with rates ranging from 10-25% for MLB pitchers, often due to overuse or premature return to play. Researchers are actively exploring new biologic manipulations, such as collagen and stem cell therapies, to further enhance healing and potentially accelerate recovery in the next 5-7 years. The original patient, Tommy John, at 83 years old, recently shared an emotional farewell message in August 2026, thanking Dr. Jobe and acknowledging the surgery that saved his career and countless others, as he battles ongoing health issues. Meanwhile, MLB continues to see players like Brian Fitzpatrick and Hunter Greene undergoing or recovering from the procedure in 2026, underscoring its continued relevance and the ongoing challenges of pitcher health.